Meet the Incumbent FDA Commissioner, Robert Califf, MD

Prominent cardiologist Robert Califf, MD, will once again serve as FDA Commissioner after being confirmed by the Senate on Feb. 15. Dr. Califf was first nominated to the position by President Joe Biden in November 2021. After graduating from Duke University School of Medicine, this native of southern Carolina began readm more…

Read More

New FDA Documents on Cough/Cold Products and Annual Reporting

The Food and Drug Administration recently released two documents of interest to manufacturers and distributors of homeopathic drugs. The first is a “consumer update” concerning the use of cough/cold products in young children. It specifically calls attention to the fact that homeopathic products have never been reviewed by the agency readm more…

Read More

FDA’s Growing Expertise in Homeopathic Manufacturing

  By George Bernstein, PhD If you have participated in AAHP Summits over the past couple of years, you are no doubt aware that FDA has raised the bar regarding compliance by homeopathic manufacturers with 21 CFR Part 211 (GMPs). I have been present in the audit room during FDA readm more…

Read More

An In-Depth Review of AAHP’s 2021 Summit

By Eric L. Foxman, Pharmacist, AAHP Secretary Having listened to the speakers at AAHP’s 2021 Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2, I came away with several thoughts that will be important to manufacturers and marketers in the coming months and years. But first a huge thank you readm more…

Read More

Success: Implementing HPUS Guidelines for FDA Compliance, Part 2

By Mark Land, AAHP President Co-hosted by AAHP and HPCUS on June 15, the Summit: Implementing HPUS Guidelines for FDA Compliance, Part 2 was an overwhelming success from multiple perspectives. This was the second installment of a compliance program being developed by the Homeopathic Pharmacopoeia Convention of the United States readm more…

Read More

International Coalition of Homeopathic Associations

By Mark Land, AAHP President David Skinner of the Canadian Homeopathic Pharmaceutical Association recently wrote that there is a need for an international coalition of homeopathic associations. He makes this recommendation based the perceived need to monitor and respond to the international implications of actions taken by individual regulators. David readm more…

Read More

Homeopathic Pharmacopoeia Convention Activities 2020–2021

In early May, Eric Foxman, AAHP Secretary and Senior Scientist with HCPUS, presented a webinar on updates and activities of the Homeopathic Pharmacopoeia Convention of the United States. He noted that over the past 12 months, the HPCUS held almost 40 meetings; the pandemic circumstances forced all to be held readm more…

Read More

The Environment for Homeopathy in Canada

By David Skinner, Association Manager, Canadian Homeopathic Pharmaceutical Association In the global context, Canada is a very small market, but the dynamics are no different than in other large markets like the United States. Above the 49th parallel, there are professional critics of all things falling outside the modern science readm more…

Read More